• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤干细胞与免疫微环境

Cancer Stem Cells in the Immune Microenvironment.

机构信息

Seoul National University College of Medicine, Seoul, Republic of Korea.

SillaJen, Inc., Seoul, Republic of Korea.

出版信息

Adv Exp Med Biol. 2021;1187:245-266. doi: 10.1007/978-981-32-9620-6_12.

DOI:10.1007/978-981-32-9620-6_12
PMID:33983582
Abstract

Cancer stem cells are a subpopulation of cancer cells responsible for the most demanding and aggressive cancer cell phenotypes: therapy resistance, a self-protective feature of stem cells; distant metastasis, requiring anchorage independence for survival in the circulation; and recurrence, which is related to the dormant-active cycling of stem cells. Normal tissues are composed of parenchymal cells, supportive connective components, and cellular disposal systems for removing the products of physiological wear and tear. Cancer stem cells develop from normal counterparts and progressively interact with their microenvironments, modifying and conditioning the cancer microenvironment. Cancer-associated myeloid cells constitute a major element of the cancer microenvironment. During the process of carcinogenesis, cancer stem cells and their intimately associated myeloid cells mutually interact and evolve, such that the cancer cells potentiate the activity of the myeloid cells and, in return, the myeloid cells increase cancer stem cell characteristics. Normal myeloid cells function as key accessory cells to maintain homeostasis in normal tissues and organs; in cancers, these cells co-evolve with the malignant parenchymal cells and are involved in every aspect of cancer cell biology, including proliferation, invasion, distant metastasis, and the development of resistance to therapy. In this way, cancer-associated myeloid cells provide two of the key hallmarks of cancer: evasion of immune destruction and cancer-promoting inflammation.

摘要

癌症干细胞是一群负责表现出最具侵袭性和耐药性的肿瘤细胞的亚群

耐药性是干细胞的自我保护特性;远处转移需要在循环中具有锚定独立性以存活;复发与干细胞的休眠-激活循环有关。正常组织由实质细胞、支持性结缔组织成分和细胞处理系统组成,用于清除生理磨损的产物。癌症干细胞源自正常细胞,并逐渐与其微环境相互作用,改变和调节肿瘤微环境。与癌症相关的髓系细胞构成了肿瘤微环境的主要成分。在癌变过程中,癌症干细胞及其密切相关的髓系细胞相互作用并共同进化,使得癌细胞增强了髓系细胞的活性,而髓系细胞则增加了癌症干细胞的特征。正常的髓系细胞作为维持正常组织和器官内稳态的关键辅助细胞发挥作用;在癌症中,这些细胞与恶性实质细胞共同进化,并参与癌细胞生物学的各个方面,包括增殖、侵袭、远处转移以及对治疗的耐药性发展。通过这种方式,与癌症相关的髓系细胞提供了癌症的两个关键特征:逃避免疫破坏和促进癌症炎症。

相似文献

1
Cancer Stem Cells in the Immune Microenvironment.肿瘤干细胞与免疫微环境
Adv Exp Med Biol. 2021;1187:245-266. doi: 10.1007/978-981-32-9620-6_12.
2
Heterogeneity and Plasticity of Breast Cancer Stem Cells.乳腺癌干细胞的异质性和可塑性。
Adv Exp Med Biol. 2019;1139:83-103. doi: 10.1007/978-3-030-14366-4_5.
3
Myeloid regulatory cells in tumor spreading and metastasis.肿瘤扩散和转移中的髓系调节细胞。
Immunobiology. 2015 Feb;220(2):236-42. doi: 10.1016/j.imbio.2014.07.017. Epub 2014 Jul 23.
4
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.调控癌症命运:肿瘤微环境在癌症干细胞静止和再激活中的作用。
Front Immunol. 2020 Oct 21;11:2166. doi: 10.3389/fimmu.2020.02166. eCollection 2020.
5
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.癌症干细胞分泌的巨噬细胞迁移抑制因子刺激髓源性抑制细胞功能并促进胶质母细胞瘤的免疫逃逸。
Stem Cells. 2016 Aug;34(8):2026-39. doi: 10.1002/stem.2393. Epub 2016 May 27.
6
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.癌症干细胞与肿瘤微环境:肿瘤异质性中的相互作用
Connect Tissue Res. 2015;56(5):414-25. doi: 10.3109/03008207.2015.1066780. Epub 2015 Aug 20.
7
Myeloid cells in circulation and tumor microenvironment of breast cancer patients.乳腺癌患者循环系统和肿瘤微环境中的髓样细胞。
Cancer Immunol Immunother. 2017 Jun;66(6):753-764. doi: 10.1007/s00262-017-1977-z. Epub 2017 Mar 10.
8
Pancreatic cancer stem cells: new insight into a stubborn disease.胰腺癌干细胞:对一种难治性疾病的新见解
Cancer Lett. 2015 Feb 28;357(2):429-37. doi: 10.1016/j.canlet.2014.12.004. Epub 2014 Dec 8.
9
Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.肿瘤休眠作为化疗耐药性和转移发展的替代步骤——临床意义。
Cell Oncol (Dordr). 2020 Apr;43(2):155-176. doi: 10.1007/s13402-019-00467-7. Epub 2019 Aug 7.
10
The gastrointestinal tumor microenvironment.胃肠道肿瘤微环境。
Gastroenterology. 2013 Jul;145(1):63-78. doi: 10.1053/j.gastro.2013.03.052. Epub 2013 Apr 10.

引用本文的文献

1
Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-regulated Redox Pathway and its Mechanism.基于氧化剂调节的氧化还原途径的肿瘤及癌症干细胞靶向治疗及其机制
Curr Comput Aided Drug Des. 2025;21(4):425-440. doi: 10.2174/0115734099299174240522115944.
2
A novel ALG10/TGF-β positive regulatory loop contributes to the stemness of colorectal cancer.一种新型的 ALG10/TGF-β 正调控环路促进结直肠癌细胞的干性。
Aging (Albany NY). 2022 Jun 9;14(11):4858-4873. doi: 10.18632/aging.204116.
3
Ubiquilin 1 suppresses the cancer stem cell-like traits of non-small cell lung cancer cells by regulating reactive oxygen species homeostasis.

本文引用的文献

1
Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles.非小细胞肺癌的免疫疗法:现状与未来障碍
Immune Netw. 2017 Dec;17(6):378-391. doi: 10.4110/in.2017.17.6.378. Epub 2017 Nov 24.
2
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?程序性死亡蛋白1/程序性死亡配体1阻断疗法:我们找到释放抗肿瘤免疫反应的关键了吗?
Front Immunol. 2017 Dec 4;8:1597. doi: 10.3389/fimmu.2017.01597. eCollection 2017.
3
The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
泛素蛋白 1 通过调节活性氧稳态抑制非小细胞肺癌细胞的癌症干细胞样特性。
Bioengineered. 2021 Dec;12(1):7143-7155. doi: 10.1080/21655979.2021.1979353.
上皮干细胞的基质微环境:再生的模板与恶性肿瘤的制动器
Cancer Cell. 2017 Oct 9;32(4):404-410. doi: 10.1016/j.ccell.2017.08.007.
4
Cancer stem cells revisited.癌症干细胞再探。
Nat Med. 2017 Oct 6;23(10):1124-1134. doi: 10.1038/nm.4409.
5
A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment.癌症干细胞模型作为肿瘤微环境中与癌症相关成纤维细胞的起源点。
Sci Rep. 2017 Jul 28;7(1):6838. doi: 10.1038/s41598-017-07144-5.
6
Advances in cancer stem cell targeting: How to strike the evil at its root.癌症干细胞靶向治疗的新进展:如何釜底抽薪。
Adv Drug Deliv Rev. 2017 Oct 1;120:89-107. doi: 10.1016/j.addr.2017.07.013. Epub 2017 Jul 21.
7
Immune checkpoint inhibitors: the battle of giants.免疫检查点抑制剂:巨头之战。
Pharm Pat Anal. 2017 Jul;6(4):135-137. doi: 10.4155/ppa-2017-0015. Epub 2017 Jul 11.
8
Immunotherapy for Breast Cancer: What Are We Missing?乳腺癌免疫疗法:我们遗漏了什么?
Clin Cancer Res. 2017 Jun 1;23(11):2640-2646. doi: 10.1158/1078-0432.CCR-16-2569.
9
Cancer stem cells: at the forefront of personalized medicine and immunotherapy.癌症干细胞:个性化医学和免疫疗法的前沿。
Curr Opin Pharmacol. 2017 Aug;35:1-11. doi: 10.1016/j.coph.2017.04.006. Epub 2017 May 18.
10
The impact of melanoma genetics on treatment response and resistance in clinical and experimental studies.黑色素瘤遗传学对临床和实验研究中治疗反应及耐药性的影响。
Cancer Metastasis Rev. 2017 Mar;36(1):53-75. doi: 10.1007/s10555-017-9657-1.